Provided by Tiger Fintech (Singapore) Pte. Ltd.

Athira Pharma, Inc.

0.2878
+0.01886.99%
Post-market: 0.29990.0121+4.20%17:29 EDT
Volume:199.54K
Turnover:55.45K
Market Cap:11.24M
PE:-0.11
High:0.2973
Open:0.2800
Low:0.2601
Close:0.2690
Loading ...

ATHA Energy Secures $10 Million for Uranium Exploration

TIPRANKS
·
22 Apr

Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained

TIPRANKS
·
03 Mar

Athira Pharma’s 2024 Financial Results and Pipeline Progress

TIPRANKS
·
01 Mar

Athira Pharma (ATHA) Gets a Hold from JMP Securities

TIPRANKS
·
28 Feb

Athira Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Athira Pharma FY 2024 GAAP EPS $(2.52) Beats $(2.54) Estimate

Benzinga
·
28 Feb

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire
·
28 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
24 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
18 Feb

Terra Uranium unveils co-ordinated exploration strategy for Athabasca Basin

Small Caps
·
06 Feb

Terra Uranium Expands Uranium Exploration with Strategic Partnerships

TIPRANKS
·
30 Jan

Terra Uranium well placed to accelerate Canadian strategy in 2025

Small Caps
·
30 Jan

Can Athira Pharma (NASDAQ:ATHA) Afford To Invest In Growth?

Simply Wall St.
·
28 Jan

Athira Pharma to pay $4M to settle False Claims Act allegations

TIPRANKS
·
07 Jan

Athira Pharma to Pay $4 Million Over Alleged Research Misconduct

Dow Jones
·
07 Jan

BRIEF-US says Athira Pharma to pay $4 mln to settle allegations of scientific research misconduct

Reuters
·
07 Jan

U.S. Justice Department Says Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research Misconduct

THOMSON REUTERS
·
07 Jan

Athira Pharma Insider Ups Holding By 111% During Year

Simply Wall St.
·
18 Dec 2024

Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development Pipeline

TIPRANKS
·
09 Nov 2024

Athira Pharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024